Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 30, 1997

View Archived Issues

SKB reports novel camptothecin analogues

New cephem antibacterial agents from Takeda

Schering-Plough claims tetrahydrofuran antifungal agents

New steroidal anesthetics from Akzo Nobel

N-oxide antibacterial compounds from Bayer

Cortex claims AMPA receptor modulators for CNS disorders

Synthelabo investigates oxazolidinones

Microcide reports new cephalosporin antibiotics

Pfizer reveals agents for hypercholesterolemia, atherosclerosis

Encouraging results reported for Merck anti-HIV combination

Triple combination therapy dramatically effective in HIV/AIDS

Famvir safe and effective in HIV-infected patients with shingles

Dutch investigators find method of improving t-PA therapy

Pilot trial of folic acid in stroke patients

NutraGenics changes name, receives patent coverage for proprietary technology

FDA clears Orphan Medical wound dressing

Pierre Fabre to market Penederm OTC product

Clinical trials to begin on novel antidepressant from Korean company

Schering Canada and University of Toronto collaborate on Alzheimer research

Candidate compound identified in Pharmacopeia/Berlex collaboration

Nobel Laureate to study bacterial resistance to nisin

Isis commences phase I testing of anti-HIV compound

TpP test accurate, rapid and reliable for early diagnosis of MI

Mylan Laboratories receives FDA approval for generic formulation

Dimethaid files second NDA for topical NSAID

Repligen and Pfizer initiate drug discovery collaboration

Bayer to market Amphotec in Canada

Meperidine generic approved

Terrapin and Sosei commence drug discovery collaboration

Cidofovir highlighted at retroviral conference

Zyflo now available in U.S.

Thalidomide: Forty years later

Potent NK1 antagonist reported by Servier

Mixed CCK-A agonist/CCK-B antagonist from Glaxo Wellcome

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....